{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:32:09Z","timestamp":1787243529121,"version":"build-2736575974"},"reference-count":26,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of T\u00fcrkiye","doi-asserted-by":"publisher","award":["119C036"],"award-info":[{"award-number":["119C036"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004410","name":"Scientific and Technological Research Council of T\u00fcrkiye","doi-asserted-by":"publisher","award":["217S060"],"award-info":[{"award-number":["217S060"]}],"id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"award":["119C036"],"award-info":[{"award-number":["119C036"]}],"id":[{"id":"https:\/\/ror.org\/04w9kkr77","id-type":"ROR","asserted-by":"publisher"}]},{"award":["217S060"],"award-info":[{"award-number":["217S060"]}],"id":[{"id":"https:\/\/ror.org\/04w9kkr77","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Objectives: The escalation of multidrug-resistant (MDR) clinically relevant bacterial isolates, including Escherichia coli and key ESKAPE pathogens, represents a critical global healthcare threat. While antimicrobial peptides (AMPs) offer promising alternatives, metabolic instability often limits their clinical use. This study investigated the therapeutic potential, antimicrobial efficacy, and resistance dynamics of peptide D-TN6 against highly resistant bacterial strains. Methods: D-TN6 efficacy was evaluated against 164 clinical isolates, including pan-drug-resistant, carbapenem-resistant, and polymyxin-resistant phenotypes. A 20-passage serial induction assay compared resistance development kinetics of D-TN6 against gentamicin over an extended period. Results: D-TN6 demonstrated potent efficacy against MRSA (minimum inhibitory concentration (MIC)90: 1 \u00b5g\/mL) and remained effective against polymyxin B-resistant Klebsiella pneumoniae (MIC90: 8 \u00b5g\/mL) and pan-drug-resistant Acinetobacter baumannii (MIC90: 8 \u00b5g\/mL). In resistance assays, while the gentamicin MIC increased 256-fold by the 17th passage, the D-TN6 MIC remained constant at 1 \u00b5g\/mL throughout the 20-passage study. Conclusions: These findings underscore D-TN6 as a robust therapeutic candidate. Its efficacy against MDR strains and its feature of low propensity for resistance development\u2014likely due to membrane disruption\u2014position D-TN6 as a promising solution for life-threatening infections where conventional last-resort agents fail.<\/jats:p>","DOI":"10.3390\/antibiotics15080813","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T09:48:31Z","timestamp":1787219311000},"page":"813","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Novel Antimicrobial Peptide Displaying Broad-Spectrum Activity Against Pan-Resistant Pathogens and Low Propensity for Resistance Development"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-2537","authenticated-orcid":false,"given":"Betul Zehra","family":"Temur","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, Graduate School of Natural and Applied Sciences, Acibadem University, Istanbul 34752, T\u00fcrkiye"},{"name":"Department of Medical Biotechnology, Graduate School of Health Sciences, Acibadem University, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-4914","authenticated-orcid":false,"given":"Esma","family":"Bolat","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Graduate School of Health Sciences, Acibadem University, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meltem","family":"Ayas","sequence":"additional","affiliation":[{"name":"Medical Laboratory Techniques, Vocational School of Health Services, Acibadem University, Istanbul 34752, T\u00fcrkiye"},{"name":"Department of Medical Microbiology, School of Medicine, Acibadem University, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seng\u00fcl Nisa","family":"Demirci","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Acibadem University, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4644-112X","authenticated-orcid":false,"given":"Nihan","family":"Unubol","sequence":"additional","affiliation":[{"name":"Medical Laboratory Techniques, Vocational School of Health Services, Acibadem University, Istanbul 34752, T\u00fcrkiye"},{"name":"Department of Medical Microbiology, School of Medicine, Acibadem University, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neval","family":"Yurttutan Uyar","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, School of Medicine, Acibadem University, Istanbul 34752, T\u00fcrkiye"},{"name":"Acibadem Labmed Clinical Laboratory, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Can","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, Graduate School of Natural and Applied Sciences, Acibadem University, Istanbul 34752, T\u00fcrkiye"},{"name":"Department of Medical Biotechnology, Graduate School of Health Sciences, Acibadem University, Istanbul 34752, T\u00fcrkiye"},{"name":"Department of Biomedical Engineering, Faculty of Engineering and Natural Sciences, Acibadem University, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7211-2026","authenticated-orcid":false,"given":"Tanil","family":"Kocagoz","sequence":"additional","affiliation":[{"name":"Department of Medical Biotechnology, Graduate School of Health Sciences, Acibadem University, Istanbul 34752, T\u00fcrkiye"},{"name":"Department of Medical Microbiology, School of Medicine, Acibadem University, Istanbul 34752, T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2174\/1872210513666190308133429","article-title":"Medicinal Plant Compounds for Combating the Multi-drug Resistant Pathogenic Bacteria: A Review","volume":"20","author":"Mulugeta","year":"2019","journal-title":"Curr. Pharm. Biotechnol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Obeng-Boateng, F., Kpordze, S.W., and Addy, F. (2024). In vitro antibacterial activity of Morinda citrifolia extracts against eight pathogenic bacteria species. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0313003"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Giuseppe, M., Midiri, A., Gerace, E., and Biondo, C. (2021). Bacterial antibiotic resistance: The most critical pathogens. Pathogens, 10.","DOI":"10.3390\/pathogens10101310"},{"key":"ref_5","unstructured":"World Health Organization (2024). WHO Bacterial Priority Pathogens List, 2024-Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance, World Health Organization."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kalpana, S., Lin, W.Y., Wang, Y.C., Fu, Y., Lakshmi, A., and Wang, H.Y. (2023). Antibiotic Resistance Diagnosis in ESKAPE Pathogens\u2014A Review on Proteomic Perspective. Diagnostics, 13.","DOI":"10.3390\/diagnostics13061014"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1007\/s00018-011-0710-x","article-title":"Multifunctional cationic host defence peptides and their clinical applications","volume":"68","author":"Yeung","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrmicro2745","article-title":"Modulating immunity as a therapy for bacterial infections","volume":"10","author":"Hancock","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2174\/0929867326666190805151654","article-title":"Antiviral Activities of Human Host Defense Peptides","volume":"27","author":"Brice","year":"2020","journal-title":"Curr. Med. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Chen, C.H., and Lu, T.K. (2020). Development and Challenges of Antimicrobial Peptides for Therapeutic Applications. Antibiotics, 9.","DOI":"10.3390\/antibiotics9010024"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"de Ullivarri, M.F., Arbulu, S., Garcia-Gutierrez, E., and Cotter, P.D. (2020). Antifungal Peptides as Therapeutic Agents. Front. Cell. Infect. Microbiol., 10.","DOI":"10.3389\/fcimb.2020.00105"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Kocagoz, T., Temur, B.Z., Unubol, N., Elmas, M.A., Kanlidere, Z., Cilingir, S., Acar, D., Boskan, G., Deveci, S.A., and Aybakan, E. (2025). Protease-Resistant, Broad-Spectrum Antimicrobial Peptides with High Antibacterial and Antifungal Activity. Life, 15.","DOI":"10.3390\/life15020242"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/phar.1922","article-title":"Role of Combination Antimicrobial Therapy for Vancomycin-Resistant Enterococcus faecium Infections: Review of the Current Evidence","volume":"37","author":"Yim","year":"2017","journal-title":"Pharmacotherapy"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Huang, C., Moradi, S., Sholeh, M., Tabaei, F.M., Lai, T., Tan, B., Meng, J., and Azizian, K. (2025). Global trends in antimicrobial resistance of Enterococcus faecium: A systematic review and meta-analysis of clinical isolates. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1505674"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41579-024-01054-w","article-title":"ESKAPE pathogens: Antimicrobial resistance, epidemiology, clinical impact and therapeutics","volume":"22","author":"Miller","year":"2024","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13756-024-01496-0","article-title":"Multidrug-resistant ESBL-producing Klebsiella pneumoniae complex in Czech hospitals, wastewaters and surface waters","volume":"13","author":"Lausova","year":"2024","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chaisaeng, S., Phetburom, N., Kasemsiri, P., Putthanachote, N., Wangnadee, N., Boueroy, P., Kerdsin, A., and Chopjitt, P. (2024). Phenotypic and Genotypic Profiles of Extended-Spectrum Beta-Lactamase-Producing Multidrug-Resistant Klebsiella pneumoniae in Northeastern Thailand. Antibiotics, 13.","DOI":"10.3390\/antibiotics13100917"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e00930-24","DOI":"10.1128\/aac.00930-24","article-title":"Synergistic antimicrobial combination of third-generation cephalosporins and polymyxin B against carbapenempolymyxin-resistant Klebsiella pneumoniae: An in vitro and in vivo analysis","volume":"68","author":"Sturaro","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"107361","DOI":"10.1016\/j.micpath.2025.107361","article-title":"Novel antibacterial agents and emerging therapies in the fight against multidrug-resistant Acinetobacter baumannii","volume":"200","author":"Oladipo","year":"2025","journal-title":"Microb. Pathog."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"9785","DOI":"10.1038\/s41598-025-90762-1","article-title":"Antimicrobial activity of cephamycins and \u03b2-lactam\/\u03b2-lactamase inhibitors against ESBL-producing Escherichia coli and Klebsiella pneumoniae under standard and high bacterial inocula","volume":"15","author":"Wi","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Talapko, J., Me\u0161trovi\u0107, T., Juzba\u0161i\u0107, M., Tomas, M., Eri\u0107, S., Aleksijevi\u0107, L.H., Beki\u0107, S., Schwarz, D., Mati\u0107, S., and Neuberg, M. (2022). Antimicrobial Peptides\u2014Mechanisms of Action, Antimicrobial Effects and Clinical Applications. Antibiotics, 11.","DOI":"10.3390\/antibiotics11101417"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhou, S., Zhuang, Y., Zhu, X., Yao, F., Li, H.Y., Li, H.F., Zou, X., Wu, J., Zhou, H., and Nuer, G. (2019). YhjX regulates the growth of Escherichia coli in the presence of a subinhibitory concentration of gentamicin and mediates the adaptive resistance to gentamicin. Front. Microbiol., 10.","DOI":"10.3389\/fmicb.2019.01180"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"El Shazely, B., Yu, G., Johnston, P.R., and Rolff, J. (2020). Resistance Evolution Against Antimicrobial Peptides in Staphylococcus aureus Alters Pharmacodynamics Beyond the MIC. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00103"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) (2003). Determination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilution. Clin. Microbiol. Infec., 9, ix\u2013xv.","DOI":"10.1046\/j.1469-0691.2003.00790.x"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e01273-20","DOI":"10.1128\/AAC.01273-20","article-title":"Systematic Investigation of Resistance Evolution to Common Antibiotics Reveals Conserved Collateral Responses across Common Human Pathogens","volume":"65","author":"Faza","year":"2020","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/813\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:12:50Z","timestamp":1787220770000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/15\/8\/813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["antibiotics15080813"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics15080813","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}